N/A
Completed N=162
Growth Mindset Psychoeducation for Modifiable Risk Factors for CMD
Depression, Anxiety
Source: ClinicalTrials.gov NCT03707522 ↗
Enrolled (actual)
162
Serious AEs
—
Results posted
Aug 2019
Primary outcomePrimary: Patient Health Questionnaire (PHQ-9; Kroenke, Spitzer & Williams, 2001) — 5.50; 4.57; 6.70; 13.14 units on a scale
Summary
The present study aims to determine the effect of presenting psychoeducation emphasizing "growth-mindset," and information on modifiable risk factors (e.g., social contact, physical activity) on engagement with modifiable risk factors. The investigators hypothesize that psychoeducation emphasizing that mental health is malleable will increase the participant's engagement with risk factors outlined in the intervention.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Patient Health Questionnaire (PHQ-9; Kroenke, Spitzer & Williams, 2001) |
5.50; 4.57; 6.70; 13.14 | — |
| PRIMARY Generalized Anxiety Disorder-7 (GAD-7; Spitzer, Kroenke, Williams & Lowe, 2006) |
3.67; 4.43; 6.90; 12.14 | — |
| SECONDARY Cognitive and Behavioral Avoidance Scale (CBAS, Ottenbreit & Dobson, 2003) |
52.1; 57.3; 54.8; 74.3 | — |
| SECONDARY Substance Use Measure (Lee et al., 2015) |
3.9; 3.2; 3.6; 4.9 | — |
| SECONDARY Positive Reframing; Brief COPE (B-COPE; Carver, 1997) |
2.9; 2.9; 2.4; 3.2 | — |
Eligibility Criteria
Inclusion Criteria
- College freshmen
Exclusion Criteria
- Not fluent in English
Data sourced from ClinicalTrials.gov (NCT03707522). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.